Lumosa Therapeutics Co., Ltd.
Clinical trials sponsored by Lumosa Therapeutics Co., Ltd., explained in plain language.
-
New stroke drug LT3001 tested in small safety trial
Disease control CompletedThis study tested a single dose of the experimental drug LT3001 in 24 adults who had an acute ischemic stroke within the past 24 hours. The main goal was to see if the drug causes dangerous bleeding in the brain compared to a placebo. The trial was small and early-stage, focused …
Phase: PHASE2 • Sponsor: Lumosa Therapeutics Co., Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New pain shot could ease hemorrhoid surgery recovery
Symptom relief CompletedThis study tested a single injection of a long-acting painkiller (SDE) in 221 adults recovering from hemorrhoid surgery. Half received the shot, half a placebo, and pain levels were tracked for 48 hours. The goal was to see if SDE provides better pain relief and reduces the need …
Phase: PHASE2, PHASE3 • Sponsor: Lumosa Therapeutics Co., Ltd. • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC